SYNLOGIC, INC. (SYBX) Form 10-Q Quarterly Reports
SYNLOGIC, INC. (SYBX) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SYBX
CIK: 1527599
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerJohn Green
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-14 | 2026-07-27 | 4 | 0001193125-26-352228 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344789 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-29 | — | SCHEDULE 13D/A Filing | 0001072613-26-000599 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-29 | — | SCHEDULE 13D/A Filing | 0000921895-26-001889 | View SEC Doc Filr Page |
| 425 | 2026-07-29 | — | 425 | 0001193125-26-322162 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-27 | 8-K | 0001193125-26-322160 | View SEC Doc Filr Page |
| 25-NSE | 2026-05-18 | — | 25-NSE Filing | 0001354457-26-000470 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001193125-26-224171 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-30 | 2025-12-31 | 10-K/A | 0001193125-26-197468 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-04-06 | — | SCHEDULE 13D/A Filing | 0000921895-26-000926 | View SEC Doc Filr Page |
| 10-K | 2026-03-12 | 2025-12-31 | 10-K | 0001193125-26-104262 | View SEC Doc Filr Page |
| 8-K/A | 2026-01-29 | 2026-01-16 | 8-K/A | 0001193125-26-028333 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-01-23 | — | SCHEDULE 13G Filing | 0001957912-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-01-20 | 2026-01-16 | 8-K | 0001193125-26-016040 | View SEC Doc Filr Page |
| 8-K | 2025-12-16 | 2025-12-15 | 8-K | 0001193125-25-319653 | View SEC Doc Filr Page |
| 8-K | 2025-11-26 | 2025-11-21 | 8-K | 0001193125-25-300824 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | 10-Q | 0001193125-25-280270 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-13 | — | SCHEDULE 13G/A Filing | 0000921895-25-003023 | View SEC Doc Filr Page |
| ARS | 2025-11-12 | 2024-12-31 | ARS | 0001193125-25-277877 | View SEC Doc Filr Page |
| DEF 14A | 2025-11-12 | 2025-12-15 | DEF 14A | 0001193125-25-277747 | View SEC Doc Filr Page |
| 4 | 2025-10-31 | 2025-10-29 | 4 | 0001193125-25-260649 | View SEC Doc Filr Page |
| EFFECT | 2025-08-20 | — | EFFECT Filing | 9999999995-25-002691 | View SEC Doc Filr Page |
| CORRESP | 2025-08-18 | — | CORRESP Filing | 0001193125-25-182671 | View SEC Doc Filr Page |
| S-3/A | 2025-08-15 | — | S-3/A | 0001193125-25-181891 | View SEC Doc Filr Page |
| UPLOAD | 2025-08-13 | — | UPLOAD Filing | 0000000000-25-008506 | View SEC Doc Filr Page |